Sign Up
OverviewAPI
Multiple law firms are involved in class action lawsuits against Ventyx Biosciences and bluebird bio, Inc. for allegedly making false statements that affected investor interests. The lawsuits focus on misleading information related to clinical products, business prospects, and FDA approvals, resulting in stock price drops and financial losses.

Ask a question